Willasch, A. M. Et Al. 2020. Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. BONE MARROW TRANSPLANTATION , vol.55, no.8 , 1540-1551.

Willasch, A. M., Peters, C., Sedlacek, P., Dalle, J., Kitra-Roussou, V., Yesilipek, A., ... Wachowiak, J.(2020). Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. BONE MARROW TRANSPLANTATION , vol.55, no.8, 1540-1551.

Willasch, Andre Et Al. "Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study," BONE MARROW TRANSPLANTATION , vol.55, no.8, 1540-1551, 2020

Willasch, Andre M. Et Al. "Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study." BONE MARROW TRANSPLANTATION , vol.55, no.8, pp.1540-1551, 2020

Willasch, A. M. Et Al. (2020) . "Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study." BONE MARROW TRANSPLANTATION , vol.55, no.8, pp.1540-1551.

@article{article, author={Andre Manfred Willasch Et Al. }, title={Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study}, journal={BONE MARROW TRANSPLANTATION}, year=2020, pages={1540-1551} }